Keyphrases
Tumor
100%
Equilibrative nucleoside Transporter
100%
Gemcitabine
100%
Surface Expression
100%
Docetaxel
100%
Gemcitabine Resistance
100%
Arginine Starvation
100%
ADI-PEG20
85%
ASS1
85%
C-Myc
71%
Sarcoma
28%
Protein Expression
14%
Tumor Cell Lines
14%
Uptake Assay
14%
Therapeutic Potential
14%
Living Cells
14%
Tumor Inhibition
14%
Melanoma Cells
14%
Metabolic Reprogramming
14%
Ongoing Clinical Trials
14%
Cytosine
14%
Pancreatic Cancer Cell Lines
14%
Arginine Deiminase
14%
RRM2
14%
Drug Combination Study
14%
E2F Transcription Factor 1 (E2F1)
14%
Pyrimidine Pathway
14%
C-Myc Inhibitor
14%
Medicine and Dentistry
Neoplasm
100%
Arginine
100%
Gemcitabine
100%
Docetaxel
100%
Connective Tissue Cancer
25%
Clinical Trial
12%
Cancer
12%
Cell Surface
12%
Protein Expression
12%
Tumor Cell Line
12%
Cell Line
12%
Uptake Assay
12%
Cancer Inhibition
12%
Melanoma Cell Line
12%
Fluorescein Isothiocyanate
12%
Combination Drug
12%
Oncogene C Myc
12%
Pancreatic Cancer Cell Line
12%
Cytosine
12%
Arginine Deiminase
12%
Pyrimidine
12%
Immunology and Microbiology
Arginine
100%
Cell Line
50%
Protein Expression
50%
Cell Surface
50%
Tumor Cell Line
50%
Growth Inhibition
50%
Melanoma Cell Line
50%
Oncogene C Myc
50%
Arginine Deiminase
50%
Pancreatic Cancer Cell Line
50%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Arginine
100%
Gemcitabine
100%
Docetaxel
100%
Connective Tissue Cancer
25%
Clinical Trial
12%
Melanoma
12%
Cancer Inhibition
12%
Pancreas Cancer
12%
Fluorescein Isothiocyanate
12%
Combination Drug
12%
Arginine Deiminase
12%
Cytosine
12%
Pyrimidine
12%
Biochemistry, Genetics and Molecular Biology
Arginine
100%
Gemcitabine
100%
Reprogramming
12%
Oncogene C Myc
12%
Clinical Trial
12%
Tumor Progression
12%
In Vivo Study
12%
Protein Expression
12%
Growth Inhibition
12%
RRM2
12%
E2F1
12%
Arginine Deiminase
12%
Cytosine
12%
Veterinary Science and Veterinary Medicine
Neoplasm
100%
Connective Tissue Cancer
33%
Reprogramming
16%
E2F1
16%
Myc
16%
Melanoma
16%
Cancer
16%
Pancreatic Cancer
16%